Nuwellis, Inc. — Form 8-K
Filed August 13, 2026 · analyzed by the 8-K Agent
8-K
▲ Likely positive
significance 72/100
What the filing says
Nuwellis (market cap ~$4.6M) reported Q2 2026 net sales of $2.0M (14% YoY growth) with gross margin improving to 76% from 56%, driven by pricing, product mix, and contract manufacturing transition. The company raised approximately $12.7M in gross proceeds across two financing events ($6.0M in June, $6.7M in July including warrant exercises), extending cash runway through Q2 2027. CEO Mike McCormick appointed June 30, 2026; Aquadex label expansion advanced to 5kg+ patients (from 20kg+); console sales increased to 9 units in Q2 2026 versus 3 in Q2 2025.
Why this rating
Material capital raise (276% of market cap) extends runway and signals investor confidence; strong margin improvement and double-digit revenue growth are operationally positive, but company remains pre-profitable with $4.8M net loss in Q2. Relative to tiny $4.6M market cap, this financing and operational progress are significant.
See more from August 13, 2026.
EDGAR·FLOW summarizes public SEC EDGAR filings with automated analysis. Materiality scores and stock-impact predictions are algorithmically generated and are not investment advice. Always verify against the source filing on SEC.gov.